Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Chamberlin

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry|April 29, 1999
The design, synthesis, and biological evaluation of analogues of the serine-threonine protein phosphatase 1 and 2A selective inhibitor microcystin LA: rational modifications imparting PP1 selectivityJ B Aggen, J M Humphrey, C M Gauss, et al.
Journal of Neurochemistry|April 1, 1997
Irreversible inhibition of high-affinity [3H]kainate binding by a novel photoactivatable analogue: (2'S,3'S,4'R)-2'-carboxy-4'-(2-diazo-1-oxo-3, 3,3-trifluoropropyl)-3'-pyrrolidinyl acetateC L Willis, D A Wacker, R D Bartlett, et al.
JAMIA Open|November 20, 2020
Evaluation of patient-level retrieval from electronic health record data for a cohort discovery taskSteven R Chamberlin, Steven D Bedrick, Aaron M Cohen, et al.
Toxicology and Applied Pharmacology|May 1, 1997
Methylation of the NMDA receptor agonist L-trans-2,3-pyrrolidine-dicarboxylate: enhanced excitotoxic potency and selectivityC L Willis, D L Dauenhauer, J M Humphrey, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Structural determinants of substrates and inhibitors: probing glutamate transporters with 2,4-methanopyrrolidine-2,4-dicarboxylateC S Esslinger, H P Koch, M P Kavanaugh, et al.
American Journal of Industrial Medicine|August 1, 1994
Half-century of cause-specific mortality experience of chemical manufacturing employeesG W Olsen, S E Lacy, J B Cartmill, et al.
Biochemistry|June 4, 1991
Site-specific incorporation of nonnatural residues during in vitro protein biosynthesis with semisynthetic aminoacyl-tRNAsJ D Bain, E S Diala, C G Glabe, et al.
The Canadian Journal of Cardiology|June 1, 1995
Successful treatment of heparin-associated thrombocytopenia and thrombosis using HirulogJ R Chamberlin, B Lewis, F Leya, et al.
Nature Materials|March 6, 2003
Mutual passivation of electrically active and isovalent impuritiesK M Yu, W Walukiewicz, J Wu, et al.
Environmental Science & Technology|January 5, 2002
Congener-independent immunoassay for microcystins and nodularinsW J Fischer, I Garthwaite, C O Miles, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry|April 29, 1999
The design, synthesis, and biological evaluation of analogues of the serine-threonine protein phosphatase 1 and 2A selective inhibitor microcystin LA: rational modifications imparting PP1 selectivityJ B Aggen, J M Humphrey, C M Gauss, et al.
Journal of Neurochemistry|April 1, 1997
Irreversible inhibition of high-affinity [3H]kainate binding by a novel photoactivatable analogue: (2'S,3'S,4'R)-2'-carboxy-4'-(2-diazo-1-oxo-3, 3,3-trifluoropropyl)-3'-pyrrolidinyl acetateC L Willis, D A Wacker, R D Bartlett, et al.
JAMIA Open|November 20, 2020
Evaluation of patient-level retrieval from electronic health record data for a cohort discovery taskSteven R Chamberlin, Steven D Bedrick, Aaron M Cohen, et al.
Toxicology and Applied Pharmacology|May 1, 1997
Methylation of the NMDA receptor agonist L-trans-2,3-pyrrolidine-dicarboxylate: enhanced excitotoxic potency and selectivityC L Willis, D L Dauenhauer, J M Humphrey, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Structural determinants of substrates and inhibitors: probing glutamate transporters with 2,4-methanopyrrolidine-2,4-dicarboxylateC S Esslinger, H P Koch, M P Kavanaugh, et al.
American Journal of Industrial Medicine|August 1, 1994
Half-century of cause-specific mortality experience of chemical manufacturing employeesG W Olsen, S E Lacy, J B Cartmill, et al.
Biochemistry|June 4, 1991
Site-specific incorporation of nonnatural residues during in vitro protein biosynthesis with semisynthetic aminoacyl-tRNAsJ D Bain, E S Diala, C G Glabe, et al.
The Canadian Journal of Cardiology|June 1, 1995
Successful treatment of heparin-associated thrombocytopenia and thrombosis using HirulogJ R Chamberlin, B Lewis, F Leya, et al.
Nature Materials|March 6, 2003
Mutual passivation of electrically active and isovalent impuritiesK M Yu, W Walukiewicz, J Wu, et al.
Environmental Science & Technology|January 5, 2002
Congener-independent immunoassay for microcystins and nodularinsW J Fischer, I Garthwaite, C O Miles, et al.
Pageof 6